Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67226 - 67250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	RAN	5901	downregulated	rosiglitazone results in decreased expression of RAN mRNA	12q24.33	A24100
Rosiglitazone	Approved Investigational	RAP1GAP	5909	downregulated	rosiglitazone results in decreased expression of RAP1GAP mRNA	1p36.12	A10216
Rosiglitazone	Approved Investigational	RAP1GAP	5909	upregulated	rosiglitazone results in increased expression of RAP1GAP mRNA	1p36.12	A22609
Rosiglitazone	Approved Investigational	RASD2	23551	upregulated	rosiglitazone results in increased expression of RASD2 mRNA	22q12.3	A22609
Rosiglitazone	Approved Investigational	RBKS	64080	upregulated	rosiglitazone results in increased expression of RBKS mRNA	2p23.2	A10216
Rosiglitazone	Approved Investigational	RBP1	5947	upregulated	rosiglitazone results in increased expression of RBP1 mRNA	3q23	A10216
Rosiglitazone	Approved Investigational	RDH10	157506	upregulated	rosiglitazone results in increased expression of RDH10 mRNA	8q21.11	A10216
Rosiglitazone	Approved Investigational	RDH5	5959	downregulated	rosiglitazone results in decreased expression of RDH5 mRNA	12q13.2	A22609
Rosiglitazone	Approved Investigational	REPS2	9185	downregulated	rosiglitazone results in decreased expression of REPS2 mRNA	Xp22.2	A10216
Rosiglitazone	Approved Investigational	RETN	56729	downregulated	rosiglitazone results in decreased expression of RETN mRNA	19p13.2	A23178
Rosiglitazone	Approved Investigational	RFLNB	359845	upregulated	rosiglitazone results in increased expression of RFLNB mRNA	17p13.3	A10216
Rosiglitazone	Approved Investigational	RFXAP	5994	downregulated	rosiglitazone results in decreased expression of RFXAP mRNA	13q13.3	A10216
Rosiglitazone	Approved Investigational	RHOBTB3	22836	upregulated	rosiglitazone results in increased expression of RHOBTB3 mRNA	5q15	A10216
Rosiglitazone	Approved Investigational	RIMS2	9699	downregulated	rosiglitazone results in decreased expression of RIMS2 mRNA	8q22.3	A22609
Rosiglitazone	Approved Investigational	RINL	126432	upregulated	rosiglitazone results in increased expression of RINL mRNA	19q13.2	A22609
Rosiglitazone	Approved Investigational	RIT1	6016	upregulated	rosiglitazone results in increased expression of RIT1 mRNA	1q22	A20427
Rosiglitazone	Approved Investigational	RLF	6018	upregulated	rosiglitazone results in increased expression of RLF mRNA	1p34.2	A20427
Rosiglitazone	Approved Investigational	RNF125	54941	downregulated	rosiglitazone results in decreased expression of RNF125 mRNA	18q12.1	A22609
Rosiglitazone	Approved Investigational	RORA	6095	downregulated	rosiglitazone results in decreased expression of RORA mRNA	15q22.2	A22609
Rosiglitazone	Approved Investigational	RPIA	22934	upregulated	rosiglitazone results in increased expression of RPIA mRNA	2p11.2	A10216
Rosiglitazone	Approved Investigational	RPL15	6138	upregulated	rosiglitazone results in increased expression of RPL15 mRNA	3p24.2	A22609
Rosiglitazone	Approved Investigational	RPS27L	51065	downregulated	rosiglitazone results in decreased expression of RPS27L mRNA	15q22.2	A20427
Rosiglitazone	Approved Investigational	RXRA	6256	downregulated	rosiglitazone results in decreased expression of RXRA mRNA	9q34.2	A20427
Rosiglitazone	Approved Investigational	SC5D	6309	downregulated	rosiglitazone results in decreased expression of SC5D mRNA	11q23.3-q24.1	A22609
Rosiglitazone	Approved Investigational	SCAMP1	9522	upregulated	rosiglitazone results in increased expression of SCAMP1 mRNA	5q14.1	A20427

Displaying entries 67226 - 67250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability